Drugplain

URELLE .12 mg/1

hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate · TABLET · Viatris Specialty LLC

No Recall History
Plain English

URELLE is a tablet containing hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate at .12 mg/1, taken oral. Manufactured by Viatris Specialty LLC.

Key Facts

Brand Name
URELLE
Generic Name
hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate
NDC Code (Product)
0037-6321
Manufacturer
Viatris Specialty LLC
Strength
.12 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Marketing Start
01/12/2015

Recall History

No Recall History

Frequently Asked Questions

What is URELLE used for?

URELLE contains hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate. It is a tablet taken oral. Consult your doctor for specific uses.

Is URELLE a controlled substance?

URELLE is not classified as a controlled substance by the DEA.

What is the generic name for URELLE?

The generic name for URELLE is hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate. There are no other listed brand versions of hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate.

What is the NDC code for URELLE .12 mg/1?

The NDC (National Drug Code) for URELLE .12 mg/1 is 0037-6321, listed by Viatris Specialty LLC.

Product NDC

0037-6321

Package NDC

0037-6321-90

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)